50 participants
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-11
- Start Date:
- 2017-07-05
- Completion:
- 2025-09-18
Conditions
- Neoplasms
Interventions
- DRUG
No Results Yet